Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections

To determine neutralizing activity against the severe acute respiratory syndrome coronavirus 2 ancestral strain and 4 variants of concern, we tested serum from 30 persons with breakthrough infection after 2-dose vaccination. Cross-variant neutralizing activity was comparable to that after 3-dose va...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pinkus Tober-Lau, Henning Gruell, Kanika Vanshylla, Willi M. Koch, David Hillus, Philipp Schommers, Isabelle Suárez, Norbert Suttorp, Leif Erik Sander, Florian Klein, Florian Kurth
Formato: Artigo
Idioma:Inglês
Publicado em: Centers for Disease Control and Prevention 2022-05-01
Colecção:Emerging Infectious Diseases
Assuntos:
COVID-19
2019 novel coronavirus disease
coronavirus disease
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
viruses
Acesso em linha:https://wwwnc.cdc.gov/eid/article/28/5/22-0271_article
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados